Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Blood Glucose | 112 | 2023 | 1244 | 4.320 |
Why?
|
Insulin | 107 | 2021 | 1454 | 4.200 |
Why?
|
Gluconeogenesis | 24 | 2020 | 121 | 3.800 |
Why?
|
Lactation | 15 | 2020 | 210 | 3.680 |
Why?
|
Glucose | 53 | 2021 | 1248 | 3.110 |
Why?
|
Diabetes Mellitus, Type 1 | 29 | 2017 | 830 | 2.930 |
Why?
|
Hypoglycemia | 28 | 2017 | 213 | 2.850 |
Why?
|
Glucagon | 51 | 2017 | 196 | 2.830 |
Why?
|
Leucine | 59 | 2006 | 352 | 2.820 |
Why?
|
Milk, Human | 11 | 2022 | 277 | 2.570 |
Why?
|
Insulin Resistance | 23 | 2021 | 731 | 2.280 |
Why?
|
Galactose | 6 | 2015 | 87 | 1.880 |
Why?
|
Hypoglycemic Agents | 17 | 2023 | 586 | 1.800 |
Why?
|
Mammary Glands, Human | 5 | 2015 | 184 | 1.720 |
Why?
|
Diabetes Mellitus, Type 2 | 18 | 2024 | 1362 | 1.610 |
Why?
|
Human Growth Hormone | 8 | 2016 | 82 | 1.500 |
Why?
|
Fasting | 32 | 2018 | 349 | 1.490 |
Why?
|
Hyperglycemia | 18 | 2018 | 333 | 1.450 |
Why?
|
Dietary Carbohydrates | 7 | 2014 | 134 | 1.240 |
Why?
|
Carbon Isotopes | 18 | 2015 | 333 | 1.230 |
Why?
|
Lipodystrophy | 3 | 2023 | 44 | 1.230 |
Why?
|
Growth Hormone | 28 | 2005 | 226 | 1.200 |
Why?
|
C-Peptide | 18 | 2023 | 107 | 1.060 |
Why?
|
Proteins | 23 | 2006 | 1963 | 1.040 |
Why?
|
Insulin-Like Growth Factor I | 12 | 2011 | 630 | 1.030 |
Why?
|
Glycogenolysis | 3 | 2018 | 11 | 1.020 |
Why?
|
Lactose | 4 | 2020 | 63 | 0.980 |
Why?
|
Keto Acids | 29 | 1993 | 59 | 0.960 |
Why?
|
Amyloid | 4 | 2009 | 97 | 0.960 |
Why?
|
Hormones | 8 | 2017 | 266 | 0.910 |
Why?
|
Leptin | 2 | 2023 | 295 | 0.890 |
Why?
|
Obesity | 18 | 2022 | 2884 | 0.850 |
Why?
|
Bariatric Surgery | 2 | 2020 | 107 | 0.810 |
Why?
|
Glycolipids | 3 | 2011 | 58 | 0.800 |
Why?
|
Glycerol | 13 | 2015 | 99 | 0.800 |
Why?
|
Glutamine | 15 | 2015 | 299 | 0.780 |
Why?
|
Kinetics | 42 | 2009 | 2049 | 0.770 |
Why?
|
Breast Feeding | 5 | 2020 | 239 | 0.720 |
Why?
|
Eating | 11 | 2014 | 421 | 0.700 |
Why?
|
Prednisone | 11 | 2009 | 984 | 0.700 |
Why?
|
Triglycerides | 8 | 2014 | 603 | 0.680 |
Why?
|
Fructose | 4 | 2009 | 72 | 0.650 |
Why?
|
Diabetic Ketoacidosis | 5 | 2015 | 136 | 0.650 |
Why?
|
Fatty Acids, Nonesterified | 25 | 2009 | 159 | 0.650 |
Why?
|
Insulin Infusion Systems | 7 | 2017 | 53 | 0.650 |
Why?
|
Amino Acids | 31 | 2003 | 728 | 0.650 |
Why?
|
Ketone Bodies | 27 | 2009 | 56 | 0.630 |
Why?
|
Energy Metabolism | 11 | 2012 | 992 | 0.630 |
Why?
|
Lipid Metabolism | 5 | 2010 | 483 | 0.630 |
Why?
|
Homeostasis | 12 | 2012 | 950 | 0.630 |
Why?
|
Carbon Radioisotopes | 24 | 1997 | 116 | 0.620 |
Why?
|
Islets of Langerhans | 7 | 2013 | 229 | 0.620 |
Why?
|
Oxidation-Reduction | 26 | 2009 | 717 | 0.620 |
Why?
|
Models, Biological | 14 | 2015 | 3254 | 0.610 |
Why?
|
Glycoproteins | 3 | 2011 | 747 | 0.610 |
Why?
|
Humans | 240 | 2024 | 261506 | 0.610 |
Why?
|
Adolescent | 70 | 2024 | 31252 | 0.610 |
Why?
|
Dietary Fats | 4 | 2013 | 339 | 0.600 |
Why?
|
Dietary Sucrose | 2 | 2010 | 42 | 0.590 |
Why?
|
Milk Proteins | 2 | 2011 | 116 | 0.590 |
Why?
|
Female | 156 | 2024 | 141928 | 0.580 |
Why?
|
Gastrointestinal Agents | 2 | 2016 | 108 | 0.570 |
Why?
|
Fatty Acids | 10 | 2020 | 448 | 0.570 |
Why?
|
Glucose Tolerance Test | 12 | 2016 | 213 | 0.560 |
Why?
|
Lipids | 4 | 2013 | 644 | 0.550 |
Why?
|
Adult | 107 | 2024 | 77950 | 0.530 |
Why?
|
Brain Edema | 2 | 2015 | 86 | 0.530 |
Why?
|
Fluid Therapy | 2 | 2015 | 182 | 0.520 |
Why?
|
Ghrelin | 2 | 2012 | 79 | 0.510 |
Why?
|
Diabetes, Gestational | 2 | 2014 | 104 | 0.490 |
Why?
|
Autoantibodies | 3 | 2013 | 576 | 0.480 |
Why?
|
Child | 71 | 2024 | 29154 | 0.480 |
Why?
|
Injections, Subcutaneous | 12 | 2016 | 334 | 0.470 |
Why?
|
Adipose Tissue | 8 | 2023 | 769 | 0.470 |
Why?
|
Lipogenesis | 1 | 2014 | 76 | 0.470 |
Why?
|
Cross-Over Studies | 9 | 2020 | 460 | 0.470 |
Why?
|
Postprandial Period | 3 | 2009 | 85 | 0.470 |
Why?
|
Insulin-Secreting Cells | 2 | 2012 | 154 | 0.460 |
Why?
|
Early Medical Intervention | 1 | 2013 | 33 | 0.450 |
Why?
|
Glutamate Decarboxylase | 1 | 2013 | 44 | 0.450 |
Why?
|
Child Welfare | 1 | 2013 | 66 | 0.450 |
Why?
|
Uridine Diphosphate Galactose | 1 | 2012 | 6 | 0.440 |
Why?
|
Male | 137 | 2024 | 123000 | 0.430 |
Why?
|
Metformin | 6 | 2023 | 378 | 0.420 |
Why?
|
Liver | 23 | 2018 | 2961 | 0.410 |
Why?
|
Early Diagnosis | 1 | 2013 | 298 | 0.410 |
Why?
|
Fibrinogen | 5 | 1993 | 205 | 0.410 |
Why?
|
Gene Expression Regulation | 3 | 2013 | 4053 | 0.400 |
Why?
|
Tritium | 14 | 1995 | 200 | 0.400 |
Why?
|
Growth Disorders | 2 | 2013 | 218 | 0.400 |
Why?
|
Dogs | 30 | 1993 | 1155 | 0.390 |
Why?
|
Metabolism | 3 | 2012 | 55 | 0.390 |
Why?
|
Puberty | 7 | 2020 | 104 | 0.390 |
Why?
|
Oligosaccharides | 2 | 2022 | 110 | 0.390 |
Why?
|
Alanine | 21 | 2002 | 240 | 0.390 |
Why?
|
Body Mass Index | 8 | 2018 | 2203 | 0.380 |
Why?
|
Deuterium Oxide | 2 | 2020 | 20 | 0.370 |
Why?
|
Metabolic Networks and Pathways | 1 | 2012 | 336 | 0.370 |
Why?
|
Protein Biosynthesis | 11 | 2006 | 889 | 0.370 |
Why?
|
Gas Chromatography-Mass Spectrometry | 9 | 2008 | 95 | 0.360 |
Why?
|
Lactic Acid | 9 | 2015 | 305 | 0.360 |
Why?
|
Blood Chemical Analysis | 3 | 2021 | 118 | 0.360 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 1085 | 0.360 |
Why?
|
Gastric Emptying | 2 | 2008 | 94 | 0.340 |
Why?
|
Recombinant Proteins | 13 | 2015 | 2927 | 0.340 |
Why?
|
Caloric Restriction | 1 | 2009 | 88 | 0.330 |
Why?
|
Biomedical Research | 1 | 2015 | 806 | 0.320 |
Why?
|
Breast | 2 | 2007 | 1344 | 0.320 |
Why?
|
Blood Glucose Self-Monitoring | 5 | 2019 | 108 | 0.320 |
Why?
|
Serum Albumin | 5 | 2003 | 257 | 0.320 |
Why?
|
Hyperinsulinism | 6 | 2002 | 85 | 0.310 |
Why?
|
Suction | 1 | 2007 | 104 | 0.310 |
Why?
|
Glucocorticoids | 5 | 2009 | 629 | 0.300 |
Why?
|
Child, Preschool | 40 | 2017 | 16273 | 0.290 |
Why?
|
Radioactive Tracers | 1 | 2006 | 30 | 0.290 |
Why?
|
Body Composition | 7 | 2005 | 595 | 0.280 |
Why?
|
Isoleucine | 5 | 1991 | 29 | 0.280 |
Why?
|
Food | 3 | 2003 | 146 | 0.280 |
Why?
|
Pediatric Obesity | 3 | 2024 | 364 | 0.280 |
Why?
|
Deuterium | 13 | 2002 | 111 | 0.280 |
Why?
|
Clinical Laboratory Techniques | 1 | 2007 | 203 | 0.270 |
Why?
|
Epithelial Cells | 1 | 2013 | 1818 | 0.270 |
Why?
|
Blood Specimen Collection | 1 | 2006 | 93 | 0.270 |
Why?
|
Weight Loss | 2 | 2009 | 627 | 0.270 |
Why?
|
Diabetes Mellitus | 8 | 2013 | 1054 | 0.270 |
Why?
|
Lipolysis | 4 | 2020 | 108 | 0.260 |
Why?
|
Islet Amyloid Polypeptide | 4 | 2009 | 16 | 0.260 |
Why?
|
Microarray Analysis | 3 | 2012 | 392 | 0.260 |
Why?
|
Hydrocortisone | 16 | 1993 | 388 | 0.260 |
Why?
|
Lipid Droplets | 3 | 2011 | 49 | 0.250 |
Why?
|
Chromatography, High Pressure Liquid | 11 | 1993 | 548 | 0.240 |
Why?
|
Caprylates | 3 | 1991 | 13 | 0.240 |
Why?
|
Infusions, Intravenous | 11 | 2015 | 1382 | 0.230 |
Why?
|
Hydroxybutyrates | 15 | 1992 | 44 | 0.230 |
Why?
|
Calorimetry, Indirect | 5 | 2009 | 60 | 0.230 |
Why?
|
Epinephrine | 16 | 2003 | 255 | 0.230 |
Why?
|
Parenteral Nutrition | 6 | 1996 | 207 | 0.230 |
Why?
|
Gene Expression | 2 | 2011 | 3570 | 0.230 |
Why?
|
Phenylbutyrates | 2 | 2006 | 59 | 0.230 |
Why?
|
Lactates | 19 | 2009 | 112 | 0.220 |
Why?
|
Infant | 24 | 2022 | 13310 | 0.220 |
Why?
|
Energy Intake | 6 | 2018 | 515 | 0.210 |
Why?
|
Receptors, Ghrelin | 2 | 2012 | 35 | 0.210 |
Why?
|
Nutritional Physiological Phenomena | 2 | 2000 | 101 | 0.210 |
Why?
|
Time Factors | 20 | 2013 | 12926 | 0.210 |
Why?
|
Glycomics | 1 | 2021 | 27 | 0.200 |
Why?
|
Biosynthetic Pathways | 1 | 2021 | 46 | 0.200 |
Why?
|
Dose-Response Relationship, Drug | 8 | 2016 | 4938 | 0.200 |
Why?
|
Gene Expression Profiling | 3 | 2013 | 5159 | 0.200 |
Why?
|
Adolescent Development | 2 | 2013 | 34 | 0.200 |
Why?
|
3-Hydroxybutyric Acid | 11 | 2002 | 32 | 0.200 |
Why?
|
Phenylalanine | 2 | 1993 | 142 | 0.200 |
Why?
|
Glycogen Storage Disease Type I | 3 | 1986 | 18 | 0.200 |
Why?
|
Acidosis | 4 | 1989 | 116 | 0.200 |
Why?
|
Diabetic Nephropathies | 1 | 2023 | 183 | 0.200 |
Why?
|
Carbon Dioxide | 6 | 2000 | 313 | 0.190 |
Why?
|
Diet | 6 | 2020 | 1440 | 0.190 |
Why?
|
Receptor, Insulin | 3 | 2020 | 97 | 0.190 |
Why?
|
Reye Syndrome | 7 | 1989 | 15 | 0.190 |
Why?
|
Incretins | 1 | 2020 | 25 | 0.190 |
Why?
|
Bodily Secretions | 1 | 2020 | 12 | 0.190 |
Why?
|
Biochemistry | 1 | 2000 | 24 | 0.190 |
Why?
|
Monitoring, Physiologic | 3 | 2013 | 502 | 0.190 |
Why?
|
Adiposity | 2 | 2014 | 237 | 0.180 |
Why?
|
Polysaccharides | 1 | 2021 | 197 | 0.180 |
Why?
|
Reference Values | 14 | 2002 | 1099 | 0.180 |
Why?
|
Spleen | 1 | 2002 | 676 | 0.180 |
Why?
|
Alkenes | 1 | 1999 | 12 | 0.180 |
Why?
|
Monosaccharides | 1 | 1999 | 24 | 0.180 |
Why?
|
Blood Proteins | 4 | 1999 | 294 | 0.180 |
Why?
|
Animals | 43 | 2021 | 59536 | 0.180 |
Why?
|
Metagenome | 1 | 2020 | 176 | 0.180 |
Why?
|
Amino Acids, Branched-Chain | 6 | 1991 | 94 | 0.180 |
Why?
|
Infant, Newborn | 16 | 2015 | 8223 | 0.180 |
Why?
|
Radioisotope Dilution Technique | 9 | 2000 | 46 | 0.170 |
Why?
|
Diabetic Retinopathy | 1 | 2022 | 178 | 0.170 |
Why?
|
Fat Emulsions, Intravenous | 2 | 1991 | 70 | 0.170 |
Why?
|
Caproates | 5 | 1992 | 9 | 0.170 |
Why?
|
Wasting Syndrome | 1 | 1999 | 28 | 0.170 |
Why?
|
Sodium Bicarbonate | 4 | 1995 | 59 | 0.170 |
Why?
|
Kidney | 6 | 2015 | 2146 | 0.170 |
Why?
|
Reproducibility of Results | 6 | 2008 | 6009 | 0.170 |
Why?
|
Hyperandrogenism | 1 | 1998 | 22 | 0.160 |
Why?
|
Gastroenteritis | 1 | 2001 | 300 | 0.160 |
Why?
|
Infant, Premature | 4 | 2006 | 787 | 0.160 |
Why?
|
Prolactin | 2 | 2008 | 155 | 0.160 |
Why?
|
Carbohydrate Metabolism | 3 | 2005 | 74 | 0.160 |
Why?
|
Carbohydrates | 2 | 2014 | 68 | 0.160 |
Why?
|
Health Resources | 1 | 2019 | 168 | 0.160 |
Why?
|
Administration, Oral | 4 | 2009 | 1544 | 0.150 |
Why?
|
Longitudinal Studies | 2 | 2020 | 1945 | 0.150 |
Why?
|
Severity of Illness Index | 4 | 2017 | 4320 | 0.150 |
Why?
|
Random Allocation | 3 | 2016 | 703 | 0.150 |
Why?
|
Beverages | 2 | 2014 | 105 | 0.150 |
Why?
|
Isothiocyanates | 1 | 2017 | 44 | 0.150 |
Why?
|
Endocrine System Diseases | 3 | 2015 | 83 | 0.150 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2002 | 363 | 0.150 |
Why?
|
Registries | 2 | 2023 | 2170 | 0.150 |
Why?
|
Threonine | 2 | 1987 | 161 | 0.150 |
Why?
|
Triacetin | 2 | 1993 | 2 | 0.150 |
Why?
|
Biological Transport | 3 | 2021 | 597 | 0.150 |
Why?
|
Sodium Chloride | 2 | 2015 | 156 | 0.150 |
Why?
|
Isotope Labeling | 5 | 2009 | 142 | 0.140 |
Why?
|
Nitrogen | 5 | 1999 | 162 | 0.140 |
Why?
|
Trypsin | 3 | 1994 | 140 | 0.140 |
Why?
|
Dwarfism, Pituitary | 1 | 2016 | 8 | 0.140 |
Why?
|
Carnitine | 4 | 1991 | 94 | 0.140 |
Why?
|
Endocrinology | 2 | 2015 | 139 | 0.140 |
Why?
|
Overweight | 3 | 2017 | 484 | 0.140 |
Why?
|
Ketosis | 3 | 1989 | 16 | 0.140 |
Why?
|
Dietary Proteins | 2 | 2009 | 241 | 0.140 |
Why?
|
Lipase | 3 | 1994 | 112 | 0.140 |
Why?
|
Obesity, Morbid | 1 | 2018 | 224 | 0.130 |
Why?
|
Sodium Acetate | 1 | 2015 | 2 | 0.130 |
Why?
|
Drug Therapy, Combination | 7 | 2019 | 2315 | 0.130 |
Why?
|
Child Development | 2 | 2013 | 255 | 0.130 |
Why?
|
Isotonic Solutions | 1 | 2015 | 46 | 0.130 |
Why?
|
Antigens, CD | 1 | 2020 | 1385 | 0.130 |
Why?
|
Candy | 1 | 2014 | 7 | 0.130 |
Why?
|
Amylases | 2 | 1994 | 66 | 0.130 |
Why?
|
Community Networks | 1 | 2015 | 45 | 0.130 |
Why?
|
Pentose Phosphate Pathway | 1 | 2015 | 69 | 0.130 |
Why?
|
Consensus | 2 | 2016 | 978 | 0.130 |
Why?
|
Acetoacetates | 11 | 1990 | 20 | 0.120 |
Why?
|
Turner Syndrome | 1 | 2015 | 68 | 0.120 |
Why?
|
Evidence-Based Practice | 1 | 2015 | 117 | 0.120 |
Why?
|
Ovary | 1 | 1998 | 668 | 0.120 |
Why?
|
Ketoglutaric Acids | 1 | 1993 | 38 | 0.120 |
Why?
|
Health Care Costs | 1 | 2019 | 674 | 0.120 |
Why?
|
Hormone Replacement Therapy | 1 | 2016 | 205 | 0.120 |
Why?
|
Thinness | 1 | 2014 | 82 | 0.120 |
Why?
|
Single-Blind Method | 2 | 2014 | 409 | 0.120 |
Why?
|
Parenteral Nutrition, Total | 2 | 2008 | 140 | 0.120 |
Why?
|
Health Status Disparities | 1 | 2016 | 291 | 0.120 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2013 | 12 | 0.110 |
Why?
|
Pregnancy | 7 | 2014 | 7573 | 0.110 |
Why?
|
Viscera | 1 | 1993 | 81 | 0.110 |
Why?
|
Adrenocortical Hyperfunction | 2 | 1986 | 7 | 0.110 |
Why?
|
Morbidity | 1 | 2014 | 397 | 0.110 |
Why?
|
Cluster Analysis | 2 | 2021 | 1053 | 0.110 |
Why?
|
Body Height | 2 | 2013 | 231 | 0.110 |
Why?
|
Pancreas | 4 | 1994 | 718 | 0.110 |
Why?
|
Societies, Medical | 2 | 2015 | 1335 | 0.110 |
Why?
|
Nitrogen Isotopes | 4 | 2003 | 60 | 0.110 |
Why?
|
Food Deprivation | 1 | 2012 | 47 | 0.110 |
Why?
|
Nutrition Policy | 1 | 2013 | 111 | 0.110 |
Why?
|
Diet, High-Fat | 1 | 2014 | 241 | 0.110 |
Why?
|
Hydrogen-Ion Concentration | 5 | 1993 | 585 | 0.100 |
Why?
|
Fetal Diseases | 2 | 2015 | 388 | 0.100 |
Why?
|
Hydrolysis | 3 | 2001 | 227 | 0.100 |
Why?
|
Palmitic Acid | 2 | 2010 | 42 | 0.100 |
Why?
|
Nutrition Assessment | 1 | 2013 | 169 | 0.100 |
Why?
|
Prednisolone | 1 | 1992 | 123 | 0.100 |
Why?
|
Insulin Antagonists | 2 | 1991 | 4 | 0.100 |
Why?
|
Drug Delivery Systems | 1 | 2016 | 669 | 0.100 |
Why?
|
Infusions, Parenteral | 9 | 2007 | 191 | 0.100 |
Why?
|
Analysis of Variance | 5 | 2013 | 2307 | 0.100 |
Why?
|
Protein Carbonylation | 1 | 2010 | 7 | 0.100 |
Why?
|
Sensitivity and Specificity | 4 | 2014 | 4971 | 0.100 |
Why?
|
Anti-Obesity Agents | 1 | 2010 | 30 | 0.100 |
Why?
|
Infusion Pumps, Implantable | 2 | 2010 | 51 | 0.100 |
Why?
|
Cohort Studies | 6 | 2023 | 9244 | 0.100 |
Why?
|
Young Adult | 5 | 2018 | 21445 | 0.090 |
Why?
|
Brain Diseases | 5 | 1979 | 403 | 0.090 |
Why?
|
Incidence | 2 | 2015 | 5673 | 0.090 |
Why?
|
Adaptation, Physiological | 2 | 2003 | 360 | 0.090 |
Why?
|
Anesthesia, General | 2 | 1990 | 239 | 0.090 |
Why?
|
Isoflurane | 1 | 1990 | 67 | 0.090 |
Why?
|
Lipid Peroxidation | 1 | 2010 | 157 | 0.090 |
Why?
|
Pyruvates | 8 | 1991 | 28 | 0.090 |
Why?
|
Albumins | 1 | 1991 | 258 | 0.090 |
Why?
|
Hexoses | 1 | 2009 | 11 | 0.090 |
Why?
|
Patient Safety | 1 | 2015 | 649 | 0.090 |
Why?
|
Osmolar Concentration | 4 | 1998 | 204 | 0.090 |
Why?
|
Chemoreceptor Cells | 1 | 2009 | 16 | 0.090 |
Why?
|
Alkalosis | 1 | 1989 | 28 | 0.090 |
Why?
|
Body Weight | 6 | 2005 | 1293 | 0.090 |
Why?
|
Glycosuria | 2 | 2007 | 10 | 0.090 |
Why?
|
Sex Factors | 3 | 2013 | 2139 | 0.090 |
Why?
|
Diet, Diabetic | 1 | 2009 | 7 | 0.090 |
Why?
|
Insulinoma | 2 | 1986 | 55 | 0.090 |
Why?
|
Halothane | 1 | 1988 | 21 | 0.080 |
Why?
|
Nitrous Oxide | 1 | 1988 | 16 | 0.080 |
Why?
|
Adenoma, Islet Cell | 2 | 1986 | 27 | 0.080 |
Why?
|
Motor Activity | 1 | 2013 | 693 | 0.080 |
Why?
|
Sample Size | 1 | 2009 | 202 | 0.080 |
Why?
|
Diet, Reducing | 1 | 2009 | 87 | 0.080 |
Why?
|
Diabetes Mellitus, Experimental | 6 | 1990 | 224 | 0.080 |
Why?
|
Maple Syrup Urine Disease | 3 | 1980 | 15 | 0.080 |
Why?
|
Fatty Liver | 2 | 2009 | 235 | 0.080 |
Why?
|
Methenamine | 1 | 2008 | 5 | 0.080 |
Why?
|
Health Behavior | 1 | 2013 | 603 | 0.080 |
Why?
|
Muscular Dystrophies | 2 | 1998 | 51 | 0.080 |
Why?
|
Lactalbumin | 1 | 2007 | 11 | 0.080 |
Why?
|
Health Expenditures | 1 | 2010 | 211 | 0.080 |
Why?
|
History, 20th Century | 2 | 2021 | 574 | 0.080 |
Why?
|
Gastrointestinal Motility | 1 | 2008 | 92 | 0.080 |
Why?
|
Breath Tests | 4 | 2000 | 177 | 0.080 |
Why?
|
Circadian Rhythm | 5 | 2004 | 330 | 0.080 |
Why?
|
Biomarkers | 2 | 2022 | 5047 | 0.080 |
Why?
|
Quality Improvement | 1 | 2015 | 851 | 0.080 |
Why?
|
Mice, Inbred C57BL | 3 | 2017 | 6942 | 0.080 |
Why?
|
Body Water | 1 | 2008 | 132 | 0.080 |
Why?
|
Somatostatin | 8 | 1993 | 114 | 0.080 |
Why?
|
Emetine | 1 | 1987 | 8 | 0.080 |
Why?
|
Area Under Curve | 1 | 2009 | 700 | 0.080 |
Why?
|
Peptide Hydrolases | 2 | 1993 | 256 | 0.080 |
Why?
|
Mice | 6 | 2017 | 34495 | 0.080 |
Why?
|
Calcium | 5 | 2006 | 1537 | 0.070 |
Why?
|
Infant, Small for Gestational Age | 2 | 2002 | 59 | 0.070 |
Why?
|
Treatment Failure | 2 | 2023 | 1391 | 0.070 |
Why?
|
Hemangioendothelioma | 1 | 2007 | 35 | 0.070 |
Why?
|
Magnesium Sulfate | 1 | 2006 | 39 | 0.070 |
Why?
|
Pregnancy, Multiple | 1 | 2006 | 45 | 0.070 |
Why?
|
Age Factors | 4 | 2013 | 5377 | 0.070 |
Why?
|
Capillaries | 1 | 2006 | 99 | 0.070 |
Why?
|
Exercise Therapy | 1 | 2009 | 288 | 0.070 |
Why?
|
Bone Diseases, Metabolic | 1 | 2006 | 84 | 0.070 |
Why?
|
Pancreatic Pseudocyst | 1 | 1986 | 24 | 0.070 |
Why?
|
Texas | 2 | 2015 | 6311 | 0.070 |
Why?
|
Lung Diseases | 1 | 1992 | 717 | 0.070 |
Why?
|
Acanthosis Nigricans | 1 | 1986 | 15 | 0.070 |
Why?
|
Metabolism, Inborn Errors | 2 | 2002 | 108 | 0.070 |
Why?
|
Muscles | 4 | 1991 | 416 | 0.070 |
Why?
|
Receptors, Cell Surface | 2 | 2009 | 862 | 0.070 |
Why?
|
Drug Administration Schedule | 4 | 2007 | 3472 | 0.070 |
Why?
|
Mice, Knockout | 2 | 2012 | 5710 | 0.070 |
Why?
|
Epithelium | 1 | 2007 | 720 | 0.070 |
Why?
|
Injections, Intravenous | 5 | 1995 | 573 | 0.070 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2009 | 2796 | 0.060 |
Why?
|
Urea | 2 | 2003 | 290 | 0.060 |
Why?
|
Pancreatic Cyst | 1 | 1986 | 107 | 0.060 |
Why?
|
Mass Screening | 1 | 2013 | 1509 | 0.060 |
Why?
|
Organosilicon Compounds | 1 | 1984 | 3 | 0.060 |
Why?
|
Hypothyroidism | 1 | 2007 | 204 | 0.060 |
Why?
|
Anthropometry | 2 | 2018 | 269 | 0.060 |
Why?
|
Malignant Hyperthermia | 1 | 1984 | 23 | 0.060 |
Why?
|
Cross-Sectional Studies | 3 | 2020 | 4314 | 0.060 |
Why?
|
Actins | 1 | 2007 | 608 | 0.060 |
Why?
|
Pancreatectomy | 4 | 1990 | 652 | 0.060 |
Why?
|
Silicon | 1 | 1984 | 48 | 0.060 |
Why?
|
Age of Onset | 2 | 2019 | 827 | 0.060 |
Why?
|
Monitoring, Ambulatory | 1 | 2004 | 63 | 0.060 |
Why?
|
Androgens | 3 | 1998 | 511 | 0.060 |
Why?
|
Gastric Inhibitory Polypeptide | 2 | 2020 | 20 | 0.060 |
Why?
|
Gene Regulatory Networks | 1 | 2008 | 677 | 0.060 |
Why?
|
Transcriptome | 1 | 2013 | 1859 | 0.060 |
Why?
|
Brain | 9 | 1991 | 4113 | 0.060 |
Why?
|
Insulin Glargine | 2 | 2019 | 20 | 0.060 |
Why?
|
Intubation, Gastrointestinal | 2 | 1995 | 79 | 0.060 |
Why?
|
Middle Aged | 19 | 2020 | 86204 | 0.060 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 1986 | 223 | 0.060 |
Why?
|
Biology | 1 | 2024 | 75 | 0.060 |
Why?
|
Respiration | 3 | 2003 | 447 | 0.060 |
Why?
|
Pancreatitis | 1 | 1986 | 267 | 0.060 |
Why?
|
Glycolysis | 2 | 2005 | 519 | 0.060 |
Why?
|
Albuminuria | 1 | 2023 | 113 | 0.060 |
Why?
|
Adipocytes | 1 | 2005 | 305 | 0.060 |
Why?
|
Carbohydrate Metabolism, Inborn Errors | 3 | 1999 | 45 | 0.060 |
Why?
|
Glucosamine | 1 | 1982 | 25 | 0.050 |
Why?
|
Risk Assessment | 2 | 2013 | 6869 | 0.050 |
Why?
|
Phenotype | 2 | 2013 | 6295 | 0.050 |
Why?
|
Bone and Bones | 2 | 2006 | 619 | 0.050 |
Why?
|
Algorithms | 2 | 2015 | 3890 | 0.050 |
Why?
|
RNA | 1 | 2007 | 1013 | 0.050 |
Why?
|
Glycosyltransferases | 1 | 2022 | 34 | 0.050 |
Why?
|
Glomerular Filtration Rate | 2 | 2023 | 602 | 0.050 |
Why?
|
Bicarbonates | 5 | 1996 | 130 | 0.050 |
Why?
|
Testosterone | 2 | 1994 | 619 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2019 | 32848 | 0.050 |
Why?
|
Cell Cycle Proteins | 1 | 2011 | 2045 | 0.050 |
Why?
|
Fucosyltransferases | 1 | 2021 | 76 | 0.050 |
Why?
|
Growth | 1 | 2002 | 117 | 0.050 |
Why?
|
Enteral Nutrition | 3 | 1996 | 316 | 0.050 |
Why?
|
Software | 1 | 2008 | 1321 | 0.050 |
Why?
|
Glucose Solution, Hypertonic | 2 | 1978 | 2 | 0.050 |
Why?
|
Hospitalization | 1 | 2010 | 2083 | 0.050 |
Why?
|
Splanchnic Circulation | 2 | 1995 | 53 | 0.050 |
Why?
|
Multiple Endocrine Neoplasia | 3 | 1986 | 57 | 0.050 |
Why?
|
Life Style | 2 | 2016 | 612 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 3639 | 0.050 |
Why?
|
Glycosylation | 1 | 2021 | 213 | 0.050 |
Why?
|
Growth Substances | 1 | 2002 | 300 | 0.050 |
Why?
|
History, 18th Century | 2 | 2000 | 89 | 0.050 |
Why?
|
Gangliosides | 1 | 2021 | 95 | 0.050 |
Why?
|
Adrenocorticotropic Hormone | 2 | 1983 | 156 | 0.050 |
Why?
|
Peptide YY | 1 | 2020 | 21 | 0.050 |
Why?
|
Patient Compliance | 2 | 2019 | 667 | 0.050 |
Why?
|
Oxygen | 1 | 2005 | 754 | 0.050 |
Why?
|
Pancreatic Neoplasms | 4 | 1986 | 5061 | 0.050 |
Why?
|
Glycogen | 2 | 1999 | 80 | 0.050 |
Why?
|
Gene Knockout Techniques | 1 | 2021 | 276 | 0.050 |
Why?
|
Metabolic Clearance Rate | 5 | 2003 | 231 | 0.050 |
Why?
|
Postpartum Period | 1 | 2002 | 259 | 0.050 |
Why?
|
Glucose Clamp Technique | 4 | 1993 | 89 | 0.050 |
Why?
|
Mucins | 1 | 2021 | 285 | 0.050 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2020 | 67 | 0.050 |
Why?
|
Erythropoietin | 1 | 2021 | 205 | 0.050 |
Why?
|
Hirsutism | 1 | 1979 | 18 | 0.050 |
Why?
|
Safety | 1 | 2002 | 465 | 0.050 |
Why?
|
Prevalence | 2 | 2008 | 3260 | 0.040 |
Why?
|
Risk Factors | 3 | 2023 | 17523 | 0.040 |
Why?
|
History, 19th Century | 1 | 2000 | 154 | 0.040 |
Why?
|
Indicators and Reagents | 1 | 1999 | 128 | 0.040 |
Why?
|
Water | 1 | 2002 | 361 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2007 | 3154 | 0.040 |
Why?
|
Chromatography, Ion Exchange | 2 | 1993 | 82 | 0.040 |
Why?
|
MicroRNAs | 1 | 2013 | 2947 | 0.040 |
Why?
|
Ultrasonography | 1 | 1986 | 1863 | 0.040 |
Why?
|
Infusion Pumps | 2 | 1997 | 61 | 0.040 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 1999 | 69 | 0.040 |
Why?
|
Adenoma | 1 | 1984 | 716 | 0.040 |
Why?
|
Sex Chromosomes | 1 | 1978 | 43 | 0.040 |
Why?
|
Immunocompetence | 1 | 1999 | 75 | 0.040 |
Why?
|
Ethinyl Estradiol-Norgestrel Combination | 1 | 1998 | 2 | 0.040 |
Why?
|
Consciousness | 2 | 1989 | 56 | 0.040 |
Why?
|
Cholesterol, LDL | 1 | 2022 | 565 | 0.040 |
Why?
|
Basal Metabolism | 4 | 1996 | 88 | 0.040 |
Why?
|
Nutritional Status | 1 | 2020 | 337 | 0.040 |
Why?
|
Phosphates | 2 | 1978 | 187 | 0.040 |
Why?
|
Hypoparathyroidism | 1 | 1978 | 49 | 0.040 |
Why?
|
Infant, Low Birth Weight | 1 | 1999 | 181 | 0.040 |
Why?
|
Clitoris | 1 | 1977 | 7 | 0.040 |
Why?
|
Exome | 1 | 2024 | 1239 | 0.040 |
Why?
|
Liver Transplantation | 1 | 2007 | 1112 | 0.040 |
Why?
|
Steroid Hydroxylases | 1 | 1977 | 36 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2017 | 18 | 0.040 |
Why?
|
Costs and Cost Analysis | 1 | 2019 | 306 | 0.040 |
Why?
|
Research Design | 2 | 2016 | 1544 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 4 | 1 | 2017 | 29 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2011 | 7226 | 0.040 |
Why?
|
Vulva | 1 | 1977 | 37 | 0.040 |
Why?
|
Radiation Dosage | 1 | 1982 | 1014 | 0.040 |
Why?
|
X Chromosome | 1 | 1978 | 339 | 0.040 |
Why?
|
Drug Costs | 1 | 2019 | 144 | 0.040 |
Why?
|
Calorimetry | 2 | 2003 | 62 | 0.040 |
Why?
|
Sulfoxides | 1 | 2017 | 22 | 0.040 |
Why?
|
Cyclic AMP | 1 | 1978 | 358 | 0.040 |
Why?
|
Lipid Metabolism, Inborn Errors | 2 | 1991 | 22 | 0.040 |
Why?
|
Disorders of Sex Development | 2 | 1980 | 88 | 0.040 |
Why?
|
Risk Reduction Behavior | 1 | 2019 | 227 | 0.040 |
Why?
|
Norepinephrine | 6 | 1993 | 272 | 0.040 |
Why?
|
Lipodystrophy, Congenital Generalized | 1 | 2017 | 8 | 0.040 |
Why?
|
Self Care | 1 | 2019 | 224 | 0.040 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 1997 | 60 | 0.040 |
Why?
|
HIV-Associated Lipodystrophy Syndrome | 1 | 2017 | 29 | 0.040 |
Why?
|
Insulin-Like Growth Factor II | 1 | 1997 | 107 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2015 | 37905 | 0.040 |
Why?
|
Diabetes Complications | 1 | 2018 | 305 | 0.040 |
Why?
|
Hypopituitarism | 1 | 1976 | 33 | 0.030 |
Why?
|
Protein Deficiency | 1 | 1996 | 20 | 0.030 |
Why?
|
Birth Weight | 3 | 1974 | 374 | 0.030 |
Why?
|
Phentolamine | 6 | 1980 | 26 | 0.030 |
Why?
|
Pediatrics | 2 | 2015 | 1141 | 0.030 |
Why?
|
Absorptiometry, Photon | 2 | 2009 | 239 | 0.030 |
Why?
|
Drug Interactions | 4 | 1993 | 553 | 0.030 |
Why?
|
Adiponectin | 1 | 2016 | 163 | 0.030 |
Why?
|
Neurosecretory Systems | 1 | 1996 | 66 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2020 | 6100 | 0.030 |
Why?
|
Gonadal Steroid Hormones | 1 | 1996 | 110 | 0.030 |
Why?
|
Epilepsy | 1 | 1983 | 883 | 0.030 |
Why?
|
Nutritional Support | 1 | 1996 | 80 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 2265 | 0.030 |
Why?
|
Education | 1 | 2015 | 112 | 0.030 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2017 | 249 | 0.030 |
Why?
|
Prognosis | 1 | 2013 | 21713 | 0.030 |
Why?
|
Oxygen Consumption | 2 | 2009 | 401 | 0.030 |
Why?
|
Pilot Projects | 1 | 2002 | 2803 | 0.030 |
Why?
|
Propranolol | 6 | 1980 | 156 | 0.030 |
Why?
|
Drug Combinations | 1 | 2016 | 621 | 0.030 |
Why?
|
Genetic Variation | 1 | 2023 | 2086 | 0.030 |
Why?
|
Estrogen Replacement Therapy | 1 | 2015 | 105 | 0.030 |
Why?
|
Jejunostomy | 1 | 1994 | 52 | 0.030 |
Why?
|
Sincalide | 1 | 1994 | 37 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2023 | 14889 | 0.030 |
Why?
|
Microbiota | 1 | 2020 | 547 | 0.030 |
Why?
|
Molecular Structure | 1 | 1995 | 515 | 0.030 |
Why?
|
Adipates | 1 | 1993 | 1 | 0.030 |
Why?
|
Isotopes | 1 | 1993 | 32 | 0.030 |
Why?
|
Parents | 1 | 2001 | 998 | 0.030 |
Why?
|
Drug-Related Side Effects and Adverse Reactions | 1 | 2019 | 598 | 0.030 |
Why?
|
Chromatography, Thin Layer | 1 | 1993 | 70 | 0.030 |
Why?
|
Adipokines | 1 | 2014 | 96 | 0.030 |
Why?
|
Catecholamines | 2 | 1991 | 101 | 0.030 |
Why?
|
Europe | 1 | 2015 | 649 | 0.030 |
Why?
|
Octreotide | 1 | 1994 | 118 | 0.030 |
Why?
|
Proinsulin | 1 | 1993 | 23 | 0.030 |
Why?
|
Heart Defects, Congenital | 2 | 1989 | 1697 | 0.030 |
Why?
|
Caregivers | 1 | 2019 | 677 | 0.030 |
Why?
|
Mathematics | 2 | 1990 | 136 | 0.030 |
Why?
|
Erythrocytes | 3 | 1989 | 339 | 0.030 |
Why?
|
Diet Therapy | 1 | 1973 | 52 | 0.030 |
Why?
|
Anemia, Sickle Cell | 1 | 1996 | 339 | 0.030 |
Why?
|
Arginine | 6 | 1990 | 500 | 0.030 |
Why?
|
Organ Size | 2 | 1984 | 690 | 0.030 |
Why?
|
Mice, Obese | 1 | 2012 | 104 | 0.030 |
Why?
|
Thiazoles | 1 | 2016 | 726 | 0.030 |
Why?
|
Disease Progression | 1 | 2023 | 6682 | 0.030 |
Why?
|
Rare Diseases | 1 | 2015 | 351 | 0.030 |
Why?
|
United States | 2 | 2013 | 15433 | 0.030 |
Why?
|
Duodenum | 1 | 1992 | 149 | 0.030 |
Why?
|
Cortisone | 3 | 1983 | 18 | 0.030 |
Why?
|
Coma | 1 | 1991 | 61 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2013 | 295 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 1978 | 1960 | 0.020 |
Why?
|
Sodium | 2 | 1990 | 353 | 0.020 |
Why?
|
Fruit | 1 | 2013 | 294 | 0.020 |
Why?
|
Home Care Services | 2 | 1989 | 92 | 0.020 |
Why?
|
Heart Rate | 3 | 2009 | 737 | 0.020 |
Why?
|
Dexamethasone | 3 | 2009 | 1450 | 0.020 |
Why?
|
Vegetables | 1 | 2013 | 325 | 0.020 |
Why?
|
Biological Availability | 1 | 1991 | 214 | 0.020 |
Why?
|
Acid-Base Equilibrium | 1 | 1990 | 78 | 0.020 |
Why?
|
Splenectomy | 1 | 1991 | 158 | 0.020 |
Why?
|
Intestinal Absorption | 1 | 1991 | 211 | 0.020 |
Why?
|
Methylhistidines | 1 | 1989 | 10 | 0.020 |
Why?
|
Pancreatic Hormones | 1 | 1989 | 8 | 0.020 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 1989 | 71 | 0.020 |
Why?
|
Triiodothyronine | 2 | 2007 | 77 | 0.020 |
Why?
|
Body Temperature | 1 | 1990 | 158 | 0.020 |
Why?
|
Health Services | 1 | 2010 | 105 | 0.020 |
Why?
|
Hydrochloric Acid | 1 | 1989 | 19 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 2007 | 4557 | 0.020 |
Why?
|
Water-Electrolyte Balance | 2 | 1994 | 104 | 0.020 |
Why?
|
Physical Exertion | 1 | 1990 | 113 | 0.020 |
Why?
|
Thyrotropin | 2 | 2007 | 119 | 0.020 |
Why?
|
Thyroxine | 2 | 2007 | 116 | 0.020 |
Why?
|
Blood Gas Analysis | 1 | 1989 | 100 | 0.020 |
Why?
|
Metabolome | 1 | 2012 | 344 | 0.020 |
Why?
|
Cell Line | 1 | 2017 | 5114 | 0.020 |
Why?
|
Infusions, Intra-Arterial | 1 | 1989 | 171 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 2 | 1992 | 544 | 0.020 |
Why?
|
Salicylates | 1 | 1989 | 59 | 0.020 |
Why?
|
Intra-Abdominal Fat | 1 | 2009 | 95 | 0.020 |
Why?
|
Pregnancy Complications | 2 | 1973 | 526 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 2016 | 3719 | 0.020 |
Why?
|
Exercise Tolerance | 1 | 2009 | 107 | 0.020 |
Why?
|
Fatty Acid Desaturases | 1 | 1988 | 14 | 0.020 |
Why?
|
Acyl-CoA Dehydrogenase | 1 | 1988 | 6 | 0.020 |
Why?
|
Asparaginase | 1 | 2009 | 184 | 0.020 |
Why?
|
Radiography | 2 | 2006 | 1904 | 0.020 |
Why?
|
Risk | 1 | 2013 | 1972 | 0.020 |
Why?
|
Heparin | 3 | 1986 | 360 | 0.020 |
Why?
|
Scintillation Counting | 1 | 1989 | 97 | 0.020 |
Why?
|
Insulin Antibodies | 2 | 1984 | 7 | 0.020 |
Why?
|
Daunorubicin | 1 | 2009 | 301 | 0.020 |
Why?
|
Molecular Weight | 1 | 1988 | 629 | 0.020 |
Why?
|
Tissue Distribution | 1 | 1989 | 875 | 0.020 |
Why?
|
Liver Function Tests | 1 | 1988 | 173 | 0.020 |
Why?
|
Estrogens | 2 | 1996 | 751 | 0.020 |
Why?
|
Luteinizing Hormone | 2 | 1996 | 165 | 0.020 |
Why?
|
Insulin, Long-Acting | 2 | 2004 | 18 | 0.020 |
Why?
|
Lipid Mobilization | 1 | 1987 | 4 | 0.020 |
Why?
|
Gene Deletion | 1 | 2012 | 1442 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2013 | 2588 | 0.020 |
Why?
|
Ethanol | 1 | 1989 | 264 | 0.020 |
Why?
|
Regression Analysis | 1 | 2010 | 1546 | 0.020 |
Why?
|
Forearm | 1 | 1987 | 67 | 0.020 |
Why?
|
Feminization | 1 | 1986 | 4 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2009 | 624 | 0.020 |
Why?
|
Absorption | 1 | 1986 | 81 | 0.020 |
Why?
|
Hindlimb | 2 | 1990 | 105 | 0.020 |
Why?
|
Hyperaldosteronism | 1 | 1986 | 19 | 0.020 |
Why?
|
Hyperprolactinemia | 1 | 1986 | 15 | 0.020 |
Why?
|
Acromegaly | 1 | 1986 | 27 | 0.020 |
Why?
|
Calcitriol | 1 | 2006 | 127 | 0.020 |
Why?
|
Magnesium | 1 | 2006 | 160 | 0.020 |
Why?
|
Demography | 1 | 1987 | 435 | 0.020 |
Why?
|
Alkaline Phosphatase | 1 | 2006 | 207 | 0.020 |
Why?
|
Herpes Simplex | 2 | 1981 | 95 | 0.020 |
Why?
|
Niacin | 1 | 1986 | 61 | 0.020 |
Why?
|
Cushing Syndrome | 1 | 1986 | 70 | 0.020 |
Why?
|
Cardiomyopathies | 1 | 1991 | 610 | 0.020 |
Why?
|
Logistic Models | 1 | 2013 | 3441 | 0.020 |
Why?
|
Glycine | 2 | 1996 | 289 | 0.020 |
Why?
|
Phosphorus | 2 | 1975 | 65 | 0.020 |
Why?
|
Diseases in Twins | 1 | 1986 | 99 | 0.020 |
Why?
|
Exercise | 1 | 1993 | 1183 | 0.020 |
Why?
|
Insulin Lispro | 1 | 2004 | 2 | 0.020 |
Why?
|
Insulin Aspart | 1 | 2004 | 6 | 0.020 |
Why?
|
Adrenalectomy | 1 | 1986 | 188 | 0.020 |
Why?
|
Models, Theoretical | 1 | 1989 | 785 | 0.020 |
Why?
|
Hyperthyroidism | 1 | 1985 | 52 | 0.020 |
Why?
|
Ethers, Cyclic | 1 | 1984 | 16 | 0.020 |
Why?
|
Glucosephosphates | 1 | 1984 | 5 | 0.020 |
Why?
|
Cytokines | 1 | 2014 | 2809 | 0.020 |
Why?
|
Glucose-6-Phosphate | 1 | 1984 | 14 | 0.020 |
Why?
|
Vincristine | 1 | 2009 | 1511 | 0.020 |
Why?
|
Mutation | 1 | 2005 | 15179 | 0.020 |
Why?
|
Epoxy Compounds | 1 | 1984 | 55 | 0.020 |
Why?
|
Propionates | 1 | 1984 | 71 | 0.020 |
Why?
|
Palmitates | 3 | 1989 | 23 | 0.020 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 1984 | 6915 | 0.020 |
Why?
|
Intraoperative Care | 1 | 1986 | 259 | 0.020 |
Why?
|
Bone Density Conservation Agents | 1 | 2006 | 198 | 0.020 |
Why?
|
Injections | 1 | 2004 | 285 | 0.010 |
Why?
|
Granulocytes | 1 | 1984 | 224 | 0.010 |
Why?
|
Electrolytes | 1 | 1983 | 68 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2013 | 2291 | 0.010 |
Why?
|
Dehydration | 1 | 1983 | 87 | 0.010 |
Why?
|
Microchemistry | 1 | 1983 | 11 | 0.010 |
Why?
|
Chemistry | 1 | 1982 | 99 | 0.010 |
Why?
|
Chemical Phenomena | 1 | 1982 | 137 | 0.010 |
Why?
|
Pancreatic Polypeptide | 1 | 1982 | 17 | 0.010 |
Why?
|
Escherichia coli | 1 | 2009 | 1203 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 1983 | 209 | 0.010 |
Why?
|
Theophylline | 1 | 1982 | 34 | 0.010 |
Why?
|
Physical Fitness | 1 | 2003 | 122 | 0.010 |
Why?
|
Serum Globulins | 1 | 1982 | 7 | 0.010 |
Why?
|
Remission Induction | 1 | 2008 | 3569 | 0.010 |
Why?
|
Virus Diseases | 2 | 1976 | 398 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1982 | 300 | 0.010 |
Why?
|
Pedigree | 1 | 1986 | 1890 | 0.010 |
Why?
|
Carboxylic Acids | 1 | 1982 | 57 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2010 | 4892 | 0.010 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 1980 | 67 | 0.010 |
Why?
|
Surveys and Questionnaires | 1 | 2013 | 5687 | 0.010 |
Why?
|
Electronics, Medical | 1 | 1980 | 15 | 0.010 |
Why?
|
Receptors, Adrenergic | 1 | 1980 | 46 | 0.010 |
Why?
|
Pyruvate Dehydrogenase Complex Deficiency Disease | 1 | 1979 | 7 | 0.010 |
Why?
|
Mestranol | 1 | 1979 | 4 | 0.010 |
Why?
|
Norethynodrel | 1 | 1979 | 2 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2003 | 417 | 0.010 |
Why?
|
Carbon | 1 | 1980 | 149 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2009 | 7702 | 0.010 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 1979 | 40 | 0.010 |
Why?
|
Receptors, Adrenergic, beta | 1 | 1980 | 97 | 0.010 |
Why?
|
Chimera | 1 | 1980 | 145 | 0.010 |
Why?
|
Bone Development | 2 | 1996 | 83 | 0.010 |
Why?
|
Follicle Stimulating Hormone | 1 | 1979 | 241 | 0.010 |
Why?
|
Rickets | 1 | 1978 | 10 | 0.010 |
Why?
|
Polycystic Ovary Syndrome | 1 | 1979 | 75 | 0.010 |
Why?
|
Citric Acid Cycle | 2 | 1977 | 86 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 1980 | 323 | 0.010 |
Why?
|
Indicator Dilution Techniques | 1 | 1998 | 22 | 0.010 |
Why?
|
Pyruvate Carboxylase Deficiency Disease | 1 | 1977 | 2 | 0.010 |
Why?
|
Vulvar Diseases | 1 | 1977 | 17 | 0.010 |
Why?
|
Blood | 2 | 1976 | 156 | 0.010 |
Why?
|
Recurrence | 1 | 1986 | 4758 | 0.010 |
Why?
|
Muscle Proteins | 1 | 1982 | 549 | 0.010 |
Why?
|
Parathyroid Hormone | 1 | 1978 | 194 | 0.010 |
Why?
|
Mitochondria | 2 | 1991 | 1282 | 0.010 |
Why?
|
Sympatholytics | 1 | 1976 | 5 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 1973 | 4638 | 0.010 |
Why?
|
Mitochondria, Liver | 1 | 1976 | 49 | 0.010 |
Why?
|
Reticulocytes | 1 | 1996 | 55 | 0.010 |
Why?
|
Bone Diseases | 1 | 1977 | 143 | 0.010 |
Why?
|
In Vitro Techniques | 4 | 1984 | 1618 | 0.010 |
Why?
|
Hormones, Ectopic | 1 | 1976 | 10 | 0.010 |
Why?
|
Acetates | 2 | 1991 | 105 | 0.010 |
Why?
|
Vasopressins | 1 | 1976 | 62 | 0.010 |
Why?
|
Maternal-Fetal Exchange | 2 | 1973 | 90 | 0.010 |
Why?
|
Mannitol | 1 | 1975 | 54 | 0.010 |
Why?
|
Sexual Maturation | 1 | 1996 | 65 | 0.010 |
Why?
|
Acid-Base Imbalance | 1 | 1975 | 30 | 0.010 |
Why?
|
Pituitary Gland | 1 | 1976 | 150 | 0.010 |
Why?
|
Sympathetic Nervous System | 1 | 1976 | 159 | 0.010 |
Why?
|
Levodopa | 1 | 1975 | 92 | 0.010 |
Why?
|
Encephalomalacia | 1 | 1975 | 2 | 0.010 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 1996 | 167 | 0.010 |
Why?
|
Protein Binding | 1 | 1982 | 3438 | 0.010 |
Why?
|
Streptozocin | 1 | 1975 | 75 | 0.010 |
Why?
|
Parenteral Nutrition, Home | 1 | 1994 | 11 | 0.010 |
Why?
|
Hyponatremia | 1 | 1976 | 82 | 0.010 |
Why?
|
Water-Electrolyte Imbalance | 1 | 1976 | 92 | 0.010 |
Why?
|
Gastrointestinal Hormones | 1 | 1994 | 26 | 0.010 |
Why?
|
Gastric Acid | 1 | 1994 | 42 | 0.010 |
Why?
|
Umbilical Cord | 1 | 1974 | 54 | 0.010 |
Why?
|
Short Bowel Syndrome | 1 | 1994 | 60 | 0.010 |
Why?
|
Delayed-Action Preparations | 1 | 1994 | 208 | 0.010 |
Why?
|
Brain Stem | 1 | 1975 | 175 | 0.010 |
Why?
|
Gestational Age | 2 | 1974 | 1069 | 0.010 |
Why?
|
Glutamate Dehydrogenase | 1 | 1973 | 14 | 0.010 |
Why?
|
Pregnanetriol | 1 | 1973 | 2 | 0.010 |
Why?
|
17-Ketosteroids | 1 | 1973 | 4 | 0.010 |
Why?
|
Chromatography | 1 | 1973 | 49 | 0.010 |
Why?
|
Virilism | 1 | 1973 | 15 | 0.010 |
Why?
|
Veins | 1 | 1974 | 157 | 0.010 |
Why?
|
Dihydroxyphenylalanine | 1 | 1973 | 8 | 0.010 |
Why?
|
Fibroblasts | 3 | 1991 | 1682 | 0.010 |
Why?
|
Glutamates | 1 | 1973 | 130 | 0.010 |
Why?
|
Alloxan | 2 | 1982 | 4 | 0.010 |
Why?
|
Abnormalities, Multiple | 1 | 1978 | 998 | 0.010 |
Why?
|
Hemodynamics | 1 | 1976 | 935 | 0.010 |
Why?
|
Palmitic Acids | 1 | 1991 | 19 | 0.010 |
Why?
|
Idoxuridine | 1 | 1971 | 17 | 0.010 |
Why?
|
Dwarfism | 1 | 1973 | 109 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 1983 | 8865 | 0.010 |
Why?
|
Floxuridine | 1 | 1971 | 38 | 0.010 |
Why?
|
Portal System | 1 | 1991 | 34 | 0.010 |
Why?
|
Pulse | 2 | 1985 | 31 | 0.010 |
Why?
|
Monocytes | 2 | 1986 | 788 | 0.010 |
Why?
|
Genes, Recessive | 1 | 1991 | 200 | 0.010 |
Why?
|
Karyotyping | 1 | 1973 | 1022 | 0.010 |
Why?
|
Acute Disease | 1 | 1976 | 2422 | 0.010 |
Why?
|
Ammonium Chloride | 1 | 1990 | 16 | 0.010 |
Why?
|
Intubation, Intratracheal | 1 | 1975 | 445 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2009 | 10035 | 0.010 |
Why?
|
Infant, Newborn, Diseases | 1 | 1973 | 186 | 0.010 |
Why?
|
Infant, Premature, Diseases | 1 | 1973 | 245 | 0.010 |
Why?
|
Liver Circulation | 1 | 1990 | 35 | 0.010 |
Why?
|
Encephalitis | 1 | 1971 | 143 | 0.010 |
Why?
|
Perfusion | 3 | 1975 | 293 | 0.010 |
Why?
|
Periodicity | 1 | 1969 | 68 | 0.010 |
Why?
|
Leukocytes | 1 | 1991 | 422 | 0.010 |
Why?
|
Portal Vein | 2 | 1982 | 355 | 0.010 |
Why?
|
Tyrosine | 1 | 1970 | 498 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 1994 | 1081 | 0.010 |
Why?
|
Pneumococcal Infections | 1 | 1969 | 241 | 0.000 |
Why?
|
Cytomegalovirus Infections | 1 | 1971 | 462 | 0.000 |
Why?
|
Smoking | 1 | 1976 | 2440 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2009 | 14289 | 0.000 |
Why?
|
Blood Pressure | 2 | 1984 | 1467 | 0.000 |
Why?
|
Syndrome | 2 | 1979 | 1351 | 0.000 |
Why?
|
Biopsy, Needle | 1 | 1988 | 1363 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1991 | 5637 | 0.000 |
Why?
|
Injections, Intraperitoneal | 1 | 1982 | 197 | 0.000 |
Why?
|
Rats | 3 | 1975 | 6086 | 0.000 |
Why?
|
Peripheral Nerves | 1 | 1982 | 159 | 0.000 |
Why?
|
Binding Sites | 1 | 1986 | 2171 | 0.000 |
Why?
|
Autopsy | 1 | 1981 | 173 | 0.000 |
Why?
|
Kidd Blood-Group System | 1 | 1980 | 2 | 0.000 |
Why?
|
Inulin | 1 | 1980 | 20 | 0.000 |
Why?
|
Decarboxylation | 1 | 1979 | 6 | 0.000 |
Why?
|
Sex Chromosome Aberrations | 1 | 1980 | 50 | 0.000 |
Why?
|
Aged | 4 | 1994 | 70117 | 0.000 |
Why?
|
Dichloroacetic Acid | 1 | 1979 | 15 | 0.000 |
Why?
|
Fertilization | 1 | 1980 | 56 | 0.000 |
Why?
|
Meiosis | 1 | 1980 | 166 | 0.000 |
Why?
|
Functional Laterality | 1 | 1980 | 316 | 0.000 |
Why?
|
Coenzyme A | 1 | 1977 | 11 | 0.000 |
Why?
|
Chromatography, Gas | 1 | 1977 | 39 | 0.000 |
Why?
|
Necrosis | 1 | 1979 | 580 | 0.000 |
Why?
|
Citrates | 1 | 1977 | 39 | 0.000 |
Why?
|
Microbial Collagenase | 1 | 1975 | 17 | 0.000 |
Why?
|
Enzyme Activation | 1 | 1979 | 1764 | 0.000 |
Why?
|
Complement Fixation Tests | 1 | 1975 | 38 | 0.000 |
Why?
|
Glyceraldehyde | 1 | 1975 | 32 | 0.000 |
Why?
|
Missouri | 1 | 1975 | 49 | 0.000 |
Why?
|
Chickenpox | 1 | 1975 | 31 | 0.000 |
Why?
|
Receptors, Drug | 1 | 1975 | 48 | 0.000 |
Why?
|
Spermine Synthase | 1 | 1975 | 6 | 0.000 |
Why?
|
Central Nervous System | 1 | 1977 | 436 | 0.000 |
Why?
|
Mass Spectrometry | 1 | 1977 | 702 | 0.000 |
Why?
|
Stereoisomerism | 1 | 1975 | 164 | 0.000 |
Why?
|
Paramyxoviridae Infections | 1 | 1975 | 86 | 0.000 |
Why?
|
Adenoviridae Infections | 1 | 1975 | 125 | 0.000 |
Why?
|
Respiratory Syncytial Viruses | 1 | 1975 | 171 | 0.000 |
Why?
|
Cerebral Angiography | 1 | 1975 | 129 | 0.000 |
Why?
|
Genes, Dominant | 1 | 1975 | 331 | 0.000 |
Why?
|
Viruses | 1 | 1975 | 159 | 0.000 |
Why?
|
Glycogen Synthase | 1 | 1973 | 8 | 0.000 |
Why?
|
Diazoxide | 1 | 1973 | 5 | 0.000 |
Why?
|
Glucose-6-Phosphatase | 1 | 1973 | 23 | 0.000 |
Why?
|
Galactosemias | 1 | 1973 | 17 | 0.000 |
Why?
|
Liver Glycogen | 1 | 1973 | 31 | 0.000 |
Why?
|
Glycoside Hydrolases | 1 | 1973 | 37 | 0.000 |
Why?
|
Structure-Activity Relationship | 1 | 1975 | 931 | 0.000 |
Why?
|
Glucosyltransferases | 1 | 1973 | 54 | 0.000 |
Why?
|
Infant Food | 1 | 1973 | 89 | 0.000 |
Why?
|
Adrenal Gland Diseases | 1 | 1973 | 72 | 0.000 |
Why?
|
Pancreatic Diseases | 1 | 1973 | 108 | 0.000 |
Why?
|
Inclusion Bodies, Viral | 1 | 1971 | 13 | 0.000 |
Why?
|
Drug Synergism | 1 | 1975 | 1313 | 0.000 |
Why?
|
Hyperplasia | 1 | 1973 | 557 | 0.000 |
Why?
|
Phosphorylation | 1 | 1979 | 4804 | 0.000 |
Why?
|
Urine | 1 | 1971 | 143 | 0.000 |
Why?
|
Cerebrospinal Fluid | 1 | 1971 | 120 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1971 | 600 | 0.000 |
Why?
|
Saliva | 1 | 1971 | 231 | 0.000 |
Why?
|
Virulence | 1 | 1969 | 323 | 0.000 |
Why?
|
Cytomegalovirus | 1 | 1971 | 482 | 0.000 |
Why?
|
Statistics as Topic | 1 | 1969 | 445 | 0.000 |
Why?
|
Influenza, Human | 1 | 1975 | 925 | 0.000 |
Why?
|
Enzyme Inhibitors | 1 | 1975 | 1879 | 0.000 |
Why?
|
Pneumonia, Viral | 1 | 1975 | 715 | 0.000 |
Why?
|